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Background: Lower respiratory tract infection (LRTI) is a sig-
niﬁcant cause of morbidity and mortality worldwide. Surveillance
studies documented increasing occurrence of infection by resis-
tant organisms posing challenge to management and control
policy. Carbapenem-resistant Enterobacteriaceae (CRE) are a seri-
ous threat to public health. Present work is aimed to show the
susceptibility pattern in Enterobacteriaceae and non -fermenting
gramnegative bacilli (NFGNB) causing LRTI and selectivemolecular
characterization of Carbapenem resistant isolates.
Methods & Materials: The study was conducted in hospital-
ized LRTI patients of two urban teaching hospitals (January 2013
- December 2013). Bacterial isolates were identiﬁed from vali-
dated sputum, endotracheal aspirate, bronchoalveolar lavage ﬂuid
and pleural ﬂuid (n=231) by standard culture method. Antimi-
crobial susceptibility and minimal inhibitory concentration values
were determined. The clinical breakpoints for Meropenem were:
susceptible ≤1.0mg/L, intermediate 2.0–3.0mg/L, and resistant
≥ 4.0mg/L. The same for Ertapenem were: ≤0.5mg/L, 1.0mg/L,
≥2mg/L respectively. MIC value for Ertapenem ≥0.5 was set as
screening breakpoint to detect carbapenemase for Enterobac-
teriaceae. Following Imipenem MIC breakpoints were adopted
to indicate MBL production: Pseudomonas aeruginosa, ≥4g/ml;
Acinetobacter spp and other NFGNB other than P. aeruginosa,
>2g/ml.
Phenotypic evaluation for detection of beta lacta-
mases (ESBL, Amp C) and carbapenemase (KPC, MBL) were
done in Ertapenem/Imipenem non-susceptible isolates.
Ertapenem/Imipenem non susceptible Enterobacteriaceae and
NFGNB were subjected to molecular characterization of KPC/MBL
(NDM) determinants. Clinical proﬁle of patients harbouring these
genes were analysed and compared.
Results: Total Enterobacteriaceae and NFGNB (n=88) included
Klebsiella pneumoniae (n=47),Escherichia coli (n=9), Enterobacter
spp. (n=3), Citrobacter fruendii (n=1), Pseudomonas aeruginosa
(n=20) and Acinetobacter spp.(n=8).
Tigecycline and Colistin were the most effective antimicrobials
followed by Carbapenems. Total Carbapenem resistant isolates
were n=28(32%) of which 9(32%) were detected harbouring blaNDM
.No blaKPC was detected. Signiﬁcant association of blaNDM carry-
ing isolates in LRTI patients with neurological abnormality was
observed(Cerebrovascular accident patients; P value (0.025). LRTI
patients with Carbapenem resistant isolates harbouring blaNDM
gene did not have increased mortality (Figures 1 and 2).
Figure 1. Isolates identiﬁed in twohospitals and their (%) of Carbapenemresistance.
Figure 2. Resistance proﬁle of K.pneumoniae and P.aeruginosa isolate(%) tested
against broad spectrum antimicrobials.
Conclusion: Evidence of substantial percentage of Carbapenem
resistant isolates carryingblaNDM gene in thepresent clinical setting
indicates need for effective and rapid infection control measures.
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Background: Unraveling the determinants of multidrug resis-
tance (MDR) in foodanimals is eitherpoorly reportedor scarce from
northeastern India.Given thepropensity of lowandmiddle-income
countries towards unprecedented global resistance hotspots, the
present study aims to characterize MDR Escherichia coli and
Salmonella isolated from food producing animals in this part of the
country, a region of strategic signiﬁcance.
Methods & Materials: A total of 668 feacal samples randomly
collected from swine, cattle, goat, yak and avian scattered in
Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Naga-
land and Sikkim were analysed. Antimicrobial susceptibility test
against 20 antimicrobials were done including determination of
MIC values for Salmonella isolates. The conﬁrmed Salmonella (n=47)
and MDR E. coli (n=174) were subjected to molecular characteriza-
tion forMDR genes (n=19). In-vitro transfer of resistance genes and
